订阅小程序
旧版功能

Adding Cyclophosphamide to Bortezomib and Dexamethasone Was Not Associated with Improved Outcomes of Patients with Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.

Clinical Lymphoma Myeloma & Leukemia(2022)

引用 2|浏览17
关键词
Immunoglobulin light chain amyloidosis,Alkylators,AL amyloidosis,Long-term outcome,Outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要